Nextnet is a San Francisco-based life sciences AI platform that unifies the world's biomedical data into a semantic web, helping researchers find evidence-backed answers and connections across literature, genes, drugs, targets, and diseases. Its products - Nextnet Copilot and Nextnet Explorer - serve researchers at institutions including Harvard, MIT, UCSF, MD Anderson, and Columbia.
Steven Banerjee is the Founder and CEO of Nextnet, a life sciences AI platform that organizes and connects the world's biomedical knowledge. A serial biotech entrepreneur originally from New Zealand, he trained as a mechanical engineer at the University of Canterbury, served as a Doctoral Fellow at IBM Labs, and collaborated with gene sequencing pioneer Ron Davis at Stanford before founding his first venture, Mekonos - a cell and gene therapy company that raised over $40 million and was acquired. He then founded Nextnet in late 2020 to bring AI-native research tools to scientists, building a platform now used across 100+ countries by researchers at Harvard, MIT, MD Anderson, and UCSF. Nextnet's Copilot and Explorer tools are powered by a purpose-built biomedical ontology unifying data from PubMed, ChEMBL, Ensembl, and millions of scientific sources.